HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D L Halladay Selected Research

parathyroid hormone (1-38)

9/2001Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
5/2000In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D L Halladay Research Topics

Disease

3Bone Resorption
09/2001 - 08/2000
2Osteosarcoma (Osteogenic Sarcoma)
12/2000 - 05/2000
1Necrosis
01/2001
1Neoplasms (Cancer)
01/2001

Drug/Important Bio-Agent (IBA)

2parathyroid hormone (1-38)IBA
09/2001 - 05/2000
2OsteoprotegerinIBA
01/2001 - 08/2000
1CalciumIBA
09/2001
1ColforsinIBA
12/2000
1Dinoprostone (PGE2)FDA Link
12/2000
1Glycoproteins (Glycoprotein)IBA
08/2000
1Proteins (Proteins, Gene)FDA Link
05/2000
1Messenger RNA (mRNA)IBA
05/2000